{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Durvalumab Addition to Induction FOLFOX and Preoperative Chemotherapy in Locally Advanced Esophageal Adenocarcinoma"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to receive either induction FOLFOX with durvalumab or FOLFOX alone"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were patients with locally advanced resectable esophageal/GEJ adenocarcinoma"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either induction FOLFOX with durvalumab or FOLFOX alone"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the safety and efficacy of adding the anti-PD-1 antibody durvalumab to this regimen"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary endpoint was pathologic complete response (pCR) assessed post-surgery"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using [randomisation method] with allocation concealment via [method]"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was applied to [outcome assessors/patients/clinicians]"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 36 patients were randomised, with 18 in each group"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Thirty-three patients completed preoperative treatment and surgery"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "In the durvalumab group, pCR was achieved in 8 patients (22% [one-sided 90% lower bound: 13.3%]), and major pathologic response (mPR) in 22 patients (61% [one-sided 90% lower bound: 50%])"
      },
      "Harms": {
        "score": 1,
        "evidence": "Preoperative treatment was well tolerated with no new safety signals"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}